Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Support Care Cancer ; 29(8): 4529-4534, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33474595

ABSTRACT

PURPOSE: To determine the immediate pain-relieving effect of photobiomodulation therapy (PBMt) in patients with oral ulcers of chronic graft-versus-host disease (cGVHD) refractory to first line therapy with topical corticosteroids. METHODS: This retrospective study included all patients who underwent PBMt for pain relief of refractory oral cGVHD lesions. PBMt was applied using an intraoral approach to all sites with mucosal lesions, using a 940 nm InGaAsP diode laser device, with the following parameters: pulsed modulation (duty cycle of 50%), power 0.7 W, illuminated spot size 7.1 cm2, irradiance 98.6 mW/cm2, and irradiation time 90 s per point. Pain was self-assessed using a 0-to-10 scale immediately before and after PBMt. RESULTS: Data from eleven patients with a total of 56 PBMt sessions were analyzed. In 48 (85.7%) sessions, the patients reported less pain immediately after treatment, with a reduction of ≥ 50% of the initial pain level in 43 (76.8%) sessions. Mean pre- and post-treatment pain levels were 5.20 ±2.7 and 1.38 ±2.1, respectively (p < 0.001), i.e., a post-treatment reduction of 73.4% of the initial pain level. The benefits of the treatment remained for a mean of 6.50 ±5.4 days (range of 2 to 14 days). No adverse effects were reported. CONCLUSIONS: PBMt seems to be a promising treatment modality for refractory oral cGVHD lesions as a rapid pain reliever with relatively long-lasting effects.


Subject(s)
Chronic Pain/radiotherapy , Graft vs Host Disease/complications , Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy/methods , Oral Ulcer/complications , Pain Management/methods , Adolescent , Adult , Aged , Child , Child, Preschool , Chronic Disease , Chronic Pain/etiology , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Young Adult
2.
Radiother Oncol ; 156: 275-280, 2021 03.
Article in English | MEDLINE | ID: mdl-33373641

ABSTRACT

BACKGROUND: Osteoradionecrosis (ORN) of the jaw is currently defined by the development of osteonecrosis in head/neck irradiated patients, regardless of lesion exposure. To diagnose medication-related osteonecrosis of the jaw (MRONJ), a history of any radiation therapy to the jaw region must be ruled out. The aim of this study was to assess the accuracy of current osteonecrosis criteria, while introducing new modifications for improved diagnosis and treatment. METHODS: One hundred and forty-one necrotic lesions were analyzed from patients exposed to bone-modifying agents (BMAs) and/or received head and neck regional radiation therapy, where the maximal dose of radiation exposure to the jaw osteonecrosis site was calculated. Modified diagnostic criteria were used to reassess all cases and a comparison of outcomes was performed using Pearson's Chi-Square/Fisher's exact test. RESULTS: Only in patients with primary head and neck carcinomas did the maximal mean radiation dose in the necrotic jaw site reach ranges associated with ORN formation (>40 Gy), with individual cases showing exposures as low as 0-2 Gy. Based on the modified diagnostic criteria almost 2/3 of the necrotic cases diagnosed as ORN should be diagnosed as MRONJ. CONCLUSIONS: ORN diagnosis should only be considered in cases of radiation exposure >40 Gy to prevent misdiagnosis and suboptimal treatment. A modified criterion for MRONJ diagnosis is recommended where radiation exposure <40 Gy in the necrotic site is included. In cases with exposure >40 Gy and BMA administration, an additional modification to diagnostic criteria of 'medication- and radiation-related osteonecrosis of the jaw', should be used.


Subject(s)
Bone Density Conservation Agents , Jaw Diseases , Neoplasms , Osteonecrosis , Osteoradionecrosis , Humans , Jaw Diseases/diagnosis , Jaw Diseases/etiology , Necrosis , Osteonecrosis/diagnosis , Osteonecrosis/etiology , Osteoradionecrosis/diagnosis , Osteoradionecrosis/etiology
3.
Int J Oral Maxillofac Implants ; 32(5): 1051-1053, 2017.
Article in English | MEDLINE | ID: mdl-28906503

ABSTRACT

PURPOSE: To study the relation between irretrievable abutment healing caps (AHCs), temperature, and the torque required to remove the AHCs from implants. MATERIALS AND METHODS: Twenty implants, 13 mm long and 4.2 mm in diameter, were inserted into four acrylic boxes and covered with acrylic resin. An AHC was screwed into each implant, using a 30 N/cm torque. The acrylic blocks were placed in a 37°C water bath, and subsequently, a block was removed from the bath, the AHCs were cooled, and the torque needed to release each AHC from the implant was measured using a torque wrench. The cooling methods applied were contact with an ice cube for 10 or 25 seconds or spraying of endodontic refrigerant spray for 3 seconds. The control abutments were similarly tested, but without prior cooling. RESULTS: The application of ice cubes for 10 seconds reduced the mean releasing torque from 29.60 ± 1.22 N/cm to 28.55 ± 1.96 N/cm (P = .01). Cooling the AHCs with ice cubes for 25 seconds reduced the mean required releasing torque from 29.6 N/cm to 27.85 ± 1.22 N/cm (P < .001). Cooling the same abutments using endodontic refrigerant spray for 3 seconds reduced the mean releasing torque to 27.74 ± 2.13 N/cm (P < .001). CONCLUSION: Within the limitations of this study, it is possible to conclude that cooling the AHC reduces the torque required for its release from the implant. This finding may also be relevant to the removal of prosthetic abutments with irretrievable screws.


Subject(s)
Cold Temperature , Dental Abutments , Dental Implant-Abutment Design , Dental Materials/chemistry , Device Removal/methods , Alloys , Dental Prosthesis Retention/instrumentation , Dental Stress Analysis , Humans , Materials Testing , Surface Properties , Titanium/chemistry , Torque
SELECTION OF CITATIONS
SEARCH DETAIL
...